Electric aviation innovation company Joby Aviation, Inc. recently announced the completion of its acquisition of a 700,000-square-foot (approximately 65,000-square-meter) industrial facility in Dayton, Ohio.
Show original
This strategic layout aims to provide a core manufacturing base for its goal of expanding production to four electric vertical take-off and landing aircraft (eVTOLs) per month by 2027. The factory, originally owned by General Electric, will be transformed into an advanced aviation manufacturing center, marking a key step for Joby from prototype trial production to large-scale mass production. The company plans to upgrade the facility in phases, doubling its current capacity and ultimately achieving a production pace of four eVTOLs per month. The Dayton base will handle fuselage assembly, system integration, and final testing, forming a synergistic effect with the R&D center at its California headquarters.This capacity expansion plan is closely aligned with Joby's commercialization timeline. The company expects to launch commercial operations in 2025, and the establishment of the new factory will lay the foundation for rapid fleet deployment thereafter. Choosing the Dayton region, which has a long history in aviation manufacturing, allows Joby to leverage the mature local aerospace industry chain and attract top aviation engineering talent.(Note: The original text was a headline-style news brief. The industry background has been elaborated based on the core information, retaining the original time nodes and data accuracy.)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Trending news
MoreTwo oil tankers attacked in the Gulf region, pushing oil prices sharply higher at the start of trading
The latest data released by UnitedHealthcare in the United States shows that its pulmonary arterial hypertension treatment drug Tyvaso demonstrates good tolerability, and the drug’s safety profile remains consistent with previous clinical trial results.
Crypto prices
MoreBitcoin
BTC
$70,357.59
+0.95%
Ethereum
ETH
$2,062.02
+1.72%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$652.52
+1.65%
XRP
XRP
$1.39
+0.39%
USDC
USDC
$1
+0.01%
Solana
SOL
$86.97
+1.70%
TRON
TRX
$0.2906
+1.76%
Dogecoin
DOGE
$0.09349
-0.95%
Cardano
ADA
$0.2636
+0.90%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now